Friday, July 31, 2026

SCL Healthcare secures patent for technology predicting metabolic syndrome using 3cc of blood

SCL Healthcare has patented a DNA methylation technology to predict metabolic syndrome risk, enhancing disease diagnosis from blood samples.

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Ex-Korean Defense Minister Grilled on Pyongyang Drone Provocations in Insurrection Probe

A special investigation into former officials, including Yoon Suk Yeol and Kim Yong-hyun, focuses on alleged treason and foreign exchange violations.

Tag: commercialization

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

From Preclinical Development to Licensing: JNPMEDI Aims to Accelerate K-Biotech Growth With AI

JNPMEDI emphasizes the need for Korea's biotech sector to enhance global commercialization and reduce clinical trial costs using AI.

Samsung Electronics Launches Dedicated Robotics Division Under CEO to Accelerate Robot Business

Samsung Electronics is launching the RX Business Promotion Office to boost its robotics sector and develop AI-driven autonomous factories.

Samsung Bioepis Signs Teva Deal to Commercialize Opuviz in Canada, Expanding North American Biosimilar Business

Samsung Bioepis partners with Teva to launch ophthalmology biosimilar Opuviz in Canada, enhancing access to treatments for patients.

China’s Fosun Pharma invests $27.5 million in AriBio, boosting optimism for Korean Alzheimer’s drug

Fosun Pharma invests $27.5 million in South Korea's AriBio, boosting its Alzheimer’s drug development and global commercialization efforts.

Top 10 Breakthrough Research Projects from the 2026 UST Proposal Challenge

UST's Proposal Challenge showcased innovative student research aimed at solving social issues, with awards for top proposals in various fields.

Stem Cell Therapies Face Long Road to Market Despite Decades of Promise

Stem cell therapies show promise for treating diseases, but face significant commercialization challenges, including quality control and funding.

Samjin Pharmaceutical and Aribio Lab Form Vaccine Partnership to Advance Joint Development and Commercialization

Samjin Pharmaceutical partners with Aribio Lab to develop and commercialize vaccines, enhancing market adoption and R&D capabilities.

U.S., Japan and China Advance Stem Cell Commercialization While Korea Works to Close Gaps

The global stem cell therapy market is rapidly growing, but South Korea faces challenges in commercialization compared to the U.S. and Japan.

GF Fermentech Showcases Synthetic Biology CDMO Platform at SynBioBeta 2026

GF Fermentech showcased its CDMO platform at SynBioBeta 2026, emphasizing rapid commercialization and advanced production technologies.

HLB Group Appoints Yang Eun-young President of Bio Business Development Division

HLB Group appoints Yang Eun-young as President of Bio Business Development, focusing on global partnerships and commercialization strategies.

Why 20 Years of Stem Cell Therapy Research Still Lacks Proven Results

Stem cell therapy shows promise but faces hurdles in clinical applications and approvals, with few successful treatments available.

Unlocking Future Healthcare: Insights from the 2026 Data Economy Conference

Sogang University hosts the 7th Data Economy Conference to discuss healthcare data commercialization and AI's role in biohealth.

Health Ministry to build “fast track” for commercialization of AI digital medical devices

The government launches a "fast track" for AI medical devices to ease market entry and enhance clinical adoption, with $300M allocated.

Rokit Healthcare’s Groundbreaking Kidney Regeneration Patent: What It Means for Patients and the Market

Rokit Healthcare secures a U.S. patent for kidney regeneration, aiming to revolutionize treatment and collaboration with Harvard Medical School.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.